ZTS
Stock Details
ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 165.90$. Average daily volumn in 3 months 2.18M. Market cap 76.19B
Stock symbol : ZTS. Exchange : NYSE. Currency : USD Lastest price : 164.41$. Total volume : 437.98k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Zoetis Inc. (ZTS)
Last Price
164.41$Change
-1.30Volume
437.98k
| Previous Close | 165.71 |
| Open | 165.57 |
| Day Range | 164.25-166.00 |
| Bid | 0.00 x 1.1k |
| Ask | 0.00 x 1.8k |
| Volume | 437.98k |
| Average Volume | 2.18M |
| Market Cap | 76.19B |
| Beta | 0.76 |
| 52 Week Range | 124.15-201.32 |
| Trailing P/E | 36.62 |
| Foward P/E | 27.04 |
| Dividend (Yield %) | 0.91% |
| Ex-Dividend Date | 2023-04-20 |
Financial Details
Organization
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms; vaccines, which a... re biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides testing and analysis of blood, urine, and other animal samples and related products and services, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Market Cap:
76.19BRevenue:
8.08BTotal Assets:
14.93BTotal Cash:
3.58B
News about "Zoetis Inc."
Zoetis Inc. (ZTS) Shares Up Despite Recent Market Volatility
Source from : newsheater - 13 days ago
Zoetis Inc. (NYSE: ZTS)’s stock price has increased by 0.25 compared to its previous closing price of 165.82. but the company has seen a 1.02% gain in its stock price over the last five trading ...See details»
Zoetis Named One of the World’s Most Ethical Companies by Ethisphere
Source from : YAHOO!Finance - 15 days ago
Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies. In ...See details»
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
Source from : MSN - 1 month ago
Zoetis Inc. ZTS will report fourth-quarter and full-year 2022 results on Feb 14, 2023, before market open. Zoetis’ earnings surprise history has been decent so far, having surpassed ...See details»
Zoetis (ZTS) Down 6.5% Since Last Earnings Report: Can It Rebound?
Source from : Nasdaq - 12 days ago
Zoetis Inc. posted fourth-quarter 2022 adjusted earnings (excluding one-time items) of $1.15, which was in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported ...See details»
Zoetis Inc
Source from : OpenSecrets.org - 2 years ago
Zoetis Inc has not reported lobbying on specific bills in 2022. Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as ...See details»
Client Profile: Zoetis Inc
Source from : OpenSecrets.org - 1 month ago
A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...See details»
Zoetis: Q4 Earnings Snapshot
Source from : Houston Chronicle - 1 month ago
PARSIPPANY, N.J. (AP) — PARSIPPANY, N.J. (AP) — Zoetis Inc. (ZTS) on Tuesday reported fourth-quarter net income of $461 million. The Parsippany, New Jersey-based company said it had net income ...See details»
Zoetis Inc. (NYSE:ZTS) Q4 2022 Earnings Call Transcript
Source from : Insider Monkey - 1 month ago
Kristin Peck: Sure, Brandon. I will start and let Wetteny build on both of them. So, in diagnostics, first of all, just ready and are joining you from our national sales meeting actually out in ...See details»
Zoetis Named One of the World’s Most Ethical Companies by Ethisphere
Source from : PharmiWeb - 15 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #Fortune500--Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards ...See details»
Zoetis (ZTS) Down 6.5% Since Last Earnings Report: Can It Rebound?
Source from : Yahoo Finance - 12 days ago
Zoetis Inc. posted fourth-quarter 2022 adjusted earnings (excluding one-time items) of $1.15, which was in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported ...See details»
Zoetis Inc.
Source from : Wall Street Journal - 2 years ago
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»
Zoetis Inc. (NYSE:ZTS) Q4 2022 Earnings Call Transcript
Source from : Insider Monkey - 1 month ago
Kristin Peck: And our practice €“ just to build on that, our practice on that is that we do not include in our guidance or our budget if we’re expecting a late launch in the year. We’ve ...See details»
Zoetis Named One of the World's Most Ethical Companies by Ethisphere
Source from : Stockhouse - 15 days ago
Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices Zoetis is one of three pharmaceutical companies and the only standalone ...See details»
Zoetis Inc.
Source from : Barron's - 1 year ago
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...See details»